These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 17501848)
1. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes. Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848 [TBL] [Abstract][Full Text] [Related]
2. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100 [TBL] [Abstract][Full Text] [Related]
3. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database. Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045 [TBL] [Abstract][Full Text] [Related]
4. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR Headache; 2006; 46(7):1142-50. PubMed ID: 16866718 [TBL] [Abstract][Full Text] [Related]
5. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial. Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D; Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis. Martin VT; Valade D; Almas M; Hettiarachchi J; Sikes C; Albert KS; Parsons B Headache; 2007 Feb; 47(2):181-8. PubMed ID: 17300357 [TBL] [Abstract][Full Text] [Related]
7. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ; Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358 [TBL] [Abstract][Full Text] [Related]
8. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ; Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101 [TBL] [Abstract][Full Text] [Related]
9. Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Dowson AJ; Massiou H; Lainez JM; Cabarrocas X Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
11. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine. Goadsby PJ Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046 [TBL] [Abstract][Full Text] [Related]
13. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing. Brandes JL; Kudrow D; Cady R; Tiseo PJ; Sun W; Sikes CR Cephalalgia; 2005 Sep; 25(9):735-42. PubMed ID: 16109056 [TBL] [Abstract][Full Text] [Related]
14. [Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies]. Pascual J; Leira R; Lainez JM; Liaño H; Díez-Tejedor E; Navarro A; Jiménez D; Ezpeleta D; Mateos V; Madrigal M; Palacios G; Neurologia; 2004 Oct; 19(8):414-9. PubMed ID: 15470580 [TBL] [Abstract][Full Text] [Related]
15. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Gawel M; Aschoff J; May A; Charlesworth BR; Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607 [TBL] [Abstract][Full Text] [Related]
16. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R; Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698 [TBL] [Abstract][Full Text] [Related]
17. Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials. Sakai F; Diener HC; Ryan R; Poole P Curr Med Res Opin; 2004 Mar; 20(3):269-77. PubMed ID: 15025836 [TBL] [Abstract][Full Text] [Related]
18. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P; Landy S; Richardson M; Ames M Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks. Diener HC; McHarg A Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281 [TBL] [Abstract][Full Text] [Related]
20. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Diener HC; Gendolla A; Gebert I; Beneke M Headache; 2005; 45(7):874-82. PubMed ID: 15985104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]